tiprankstipranks
Swedish Orphan Biovitrum AB (GB:0MTD)
LSE:0MTD
UK Market

Swedish Orphan Biovitrum AB (0MTD) Income Statement

Compare
2 Followers

Swedish Orphan Biovitrum AB Income Statement

Last quarter (Q4 2024), Swedish Orphan Biovitrum AB's total revenue was kr7.44B, an increase of 8.65% from the same quarter last year. In Q4, Swedish Orphan Biovitrum AB's net income was kr1.40B. See Swedish Orphan Biovitrum AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 26.03Bkr 22.12Bkr 18.79Bkr 15.53Bkr 15.26B
Gross Profit
kr 20.24Bkr 17.13Bkr 14.01Bkr 12.04Bkr 12.04B
Operating Expenses
kr 14.62Bkr 13.06Bkr 10.17Bkr 8.26Bkr 7.57B
Depreciation and Amortization
kr 3.68Bkr 3.17Bkr 2.27Bkr 2.00Bkr 2.02B
EBITDA
kr 9.30Bkr 7.23Bkr 6.05Bkr 5.71Bkr 6.73B
Operating Income
kr 5.63Bkr 4.07Bkr 3.81Bkr 3.73Bkr 4.82B
Other Income/Expenses
kr -1.22Bkr -1.11Bkr -492.00Mkr -438.00Mkr -601.00M
Pretax Income
kr 4.41Bkr 2.95Bkr 3.32Bkr 3.29Bkr 4.22B
Net Income
kr 3.88Bkr 2.41Bkr 2.64Bkr 2.68Bkr 3.25B
Per Share Metrics
kr ―kr ―kr ―kr ―kr ―
Basic EPS
kr 11.37kr 7.47kr 8.52kr 8.67kr 10.52
Diluted EPS
kr 11.24kr 7.39kr 8.44kr 8.62kr 10.41
Weighted Average Shares Outstanding
341.73M 322.66M 309.48M 308.90M 308.49M
Weighted Average Shares Outstanding (Diluted)
345.56M 325.97M 312.46M 310.73M 311.61M
Currency in SEK

Swedish Orphan Biovitrum AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis